![]() ![]() Schwartz led two new clinical trials testing the use of stem cell-derived retinal pigment epithelial cells to address vision loss in people suffering from Stargardt's macular dystrophy and dry age-related macular degeneration. Schwartz is dedicated to improving both the quality of and access to specialized ophthalmology care. Through innovative teleophthalmological approaches to screen for eye diseases (such as diabetic retinopathy and ROP), Dr. Schwartzs phone number, address, insurance information, hospital affiliations and more. Schwartz’ clinical research focuses on trials of novel pharmacotherapeutic agents to discover treatments for both wet and dry age-related macular degeneration, ROP, and diabetic retinopathy. Schwartz is a Thoracic Surgeon in Parker, CO. Additionally, his focus includes development and evaluation of novel medical device technologies, imaging technologies, surgical equipment (including surgical robots), and drug delivery systems, with particular emphasis on diagnostic and treatment applications. Schwartz’ primary areas of research include early diagnosis and treatment of diseases such as macular degeneration, retinopathy of prematurity (ROP), and diabetic eye disease. David Geffen School of Medicine at UCLAĭr.Professional Affiliations Academic Appointments Comparing our findings with those reported by Schwartz and Kreiger, the risk of vision-threatening events in the fellow eye seems to be similar in patients with and without PVR.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |